HCL Tech Wins Global Contract From Novartis
India's fourth largest IT services firm HCL Technologies today said it has won a global contract from pharmaceuticals major Novartis to provide infrastructure management services.
Under the deal, HCL will provide remote infrastructure management services to the Switzerland-based pharma company across its entire data centre landscape, covering more than 70 countries across six continents.
"The deal marks an important infrastructure outsourcing contract in HCL's DACH region (Germany, Austria and Switzerland) and strengthens the company's global expertise in infrastructure management within the pharmaceutical sector," HCL Technologies said in a statement.
HCL is now managing the infrastructure environment of four of the top seven pharmaceutical companies worldwide, it added.
"Our outcome-based business models, best practices and tools deliver proven value and cost savings that help our clients to be more competitive and responsive to changing market dynamics," HCL Technologies Executive VP and Head of Infrastructure Services (EMEA) Ashish Gupta said.
Shares of HCL Technologies were trading nearly 3 per cent higher at Rs 1431.05 apiece in late-afternoon trade on the BSE.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
